Previous close | 8.81 |
Open | 8.78 |
Bid | 8.75 x 1100 |
Ask | 8.78 x 1100 |
Day's range | 8.42 - 8.91 |
52-week range | 3.06 - 9.02 |
Volume | |
Avg. volume | 2,759,118 |
Market cap | 2.038B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.13 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 10.50 |
Here is how Adma Biologics (ADMA) and ResMed (RMD) have performed compared to their sector so far this year.
ADMA Biologics ( NASDAQ:ADMA ) First Quarter 2024 Results Key Financial Results Revenue: US$81.9m (up 44% from 1Q...
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript May 9, 2024 ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to the […]